Roivant Sciences Ltd (ROIV) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Roivant Sciences Ltd (US:ROIV), trading at 34.52. In 2026, Roivant Sciences Ltd generated $8.26 Million in revenue and -$758.56 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Roivant Sciences Ltd is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 34.52
- Recent Revenue (2026): $8.26 Million
- Free Cash Flow (2026): -$758.56 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.